86 search results for screening
HERC Healthcare Full
as documented through the medical record or meeting notes. • Offers flexible hours for screening
https://www.nccn.org/docs/default-source/oncology-policy-program/herc-healthcare-full.pdf?sfvrsn=a35196bc_12021_Elevating_Cancer_Equity_Webinar_Slides
or meeting notes. Offers flexible hours for screening and treatment appointments. Offers culturally, . Supporting Access to Screening: Congress should allocate additional funding for CDC screening, ) and the Colorectal Cancer Control Program (CCCP). Congress should also allocate funds for screening that prioritizes cancers where disparities are particularly prevalent. Supporting Access to Screening, with screening, early detection and treatment support. Congress should restore funds for the National
https://www.nccn.org/docs/default-source/oncology-policy-program/2021_elevating_cancer_equity_webinar_slides.pdf?sfvrsn=e11f66e4_4Biomarkers Compendium
are included in the Biomarkers Compendium®: Diagnosis Screening Monitoring Surveillance Prediction
https://www.nccn.org/compendia-templates/compendia/biomarkers-compendiumAbout Clinical Practice Guidelines
provide recommendations for some of the key cancer prevention and screening topics as well
https://www.nccn.org/guidelines/guidelines-process/about-nccn-clinical-practice-guidelinesBiomarkers Compendium Reviewer Acknowledgment
Colorectal Cancer Screening Reid M. Ness, MD, MPH
https://www.nccn.org/compendia-templates/compendia/biomarkers-compendium/biomarkers-compendium-reviewer-acknowledgmentAbout the Guidelines
recommendations for some of the key cancer prevention and screening topics as well as supportive care
https://www.nccn.org/guidelines/about-the-guidelines2020_Letter_of_Support_for_funding_for_the_World_Health_Organization
approaches (screening for, and treating precancerous lesions) are implemented. The WHO’s Cervical Cancer, strategy to accelerate cervical cancer elimination through vaccination, screening, and treatment efforts
https://www.nccn.org/docs/default-source/oncology-policy-program/2020_letter_of_support_for_funding_for_the_world_health_organization.pdf?sfvrsn=9a845997_2Young Investigator Awards
Screening Among Black Veterans Ravi Parikh, MD, MPP, The Abramson Cancer Center
https://www.nccn.org/education-research/nccn-oncology-research-program/young-investigator-awardsYoung Investigator Awards
Cancer Institute Intervention Mapping to Improve Lung Cancer Screening Among Black Veterans Ravi
https://www.nccn.org/patientresources/patient-resources/nccn-foundation/young-investigator-awardsDeveloper API
screening, diagnosis, staging, treatment response assessment, follow-up, and surveillance. Additional
https://www.nccn.org/developer-apiCollaborators
AssociationAmerican Lung Cancer Screening Initiative (ALCSI)American Thyroid AssociationAnal Cancer
https://www.nccn.org/patientresources/patient-resources/nccn-foundation/collaboratorsMay 2024 Policy Summit Report
that a lack of this data impacts screening and approaches to discussions on how to treat
https://www.nccn.org/docs/default-source/oncology-policy-program/may-2024-policy-summit-report.pdf?sfvrsn=1db829b3_1Transparency Process
Screening and Diagnosis Panel Version: 1.2025 ( Breast Cancer Screening and Diagnosis ) Date: 2024-11-08 Transparency Panel Disclosures/Attendance Version: 1.2024 ( Breast Cancer Screening and Diagnosis ) Date: 2023-11-03 Transparency Panel Disclosures/Attendance Version: 1.2023 ( Breast Cancer Screening, Colorectal Cancer Screening Panel
https://www.nccn.org/guidelines/guidelines-process/transparency-process-and-recommendationsFellows Program
to screening, and how to discuss HRSN with patients and caregivers.• Describe the roles of other oncology
https://www.nccn.org/redirects/fellows-programUser_Guide_NCCN_Imaging_Appropriate_Use_Criteria
About NCCN Imaging AUC ™ NCCN Imaging Appropriate Use Criteria (NCCN Imaging AUC™) include information designed to support clinical decision-making around the use of imaging in patients with cancer and are based directly on the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®). NCCN Imaging AUC™ include recommendations pertaining to cancer screening, diagnosis, staging, treatment response assessment, follow-up, and surveillance. Additional information includes
https://www.nccn.org/docs/default-source/clinical/user_guide_nccn_imaging_appropriate_use_criteria.pdf?sfvrsn=46bac6f4_22020_NCCN_Letter_of_Support_for_the_World_Health_Organization
(HPV vaccination) and secondary prevention approaches (screening for, and treating precancerous
https://www.nccn.org/docs/default-source/oncology-policy-program/2020_nccn_letter_of_support_for_the_world_health_organization.pdf?sfvrsn=35ddf3d_2Business Development Program Prospectus
for Successful Cancer Screening in a Post-Covid World • Addressing the Mental Health Needs of Patients, • Health Equity- Addressing Inequities, Testing Gaps & Solutions • Continuum of Care Management: Screening
https://www.nccn.org/docs/default-source/business-policy/bd-prospectus.pdf?sfvrsn=92f4bdc8_15Equity Shared Resources
community health outreach, education, screening, and navigation services provided by bilingual/bi
https://www.nccn.org/business-policy/policy-and-advocacy-program/equity-shared-resourcesORP Grant History
to Annual Lung Cancer Screening and Diagnostic Follow-up Mary E. Cooley, PhD, RN, FAAN and Michael J, Center Optimizing the Process and Uptake of Lung Cancer Screening Among Patients, Providers, and Across, of Health Beliefs and Psychological Factors on Lung Screening and Intentions in Urban and Rural
https://www.nccn.org/education-research/nccn-oncology-research-program/orp-grant-historyAnnual Report
them to reflect the latest advances in preventive, screening, diagnostic, treatment, survivorship, • Available across 73 NCCN Guidelines, including screening and supportive care, and covering, Cancer Screening NCCN 2024 Annual Report 36 NCCN Business Development Contents > The NCCN, cancer screening and early detection, and increasing access to patient navigation. The organizations
https://www.nccn.org/docs/default-source/about/annual-report.pdf?sfvrsn=8411082_40